Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Double-blind, Randomized Conversion to Monotherapy Study to Evaluate the Efficacy and Safety of Brivaracetam in Subjects (≥ 16 to 75 Years Old) With Partial Onset Seizures

This study has been terminated.
(An interim analysis revealed the study was unlikely to attain a positive outcome for the efficacy analysis. No safety concerns were detected)
Information provided by (Responsible Party):
UCB Pharma Identifier:
First received: June 12, 2008
Last updated: August 26, 2014
Last verified: September 2012
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: March 2010
  Primary Completion Date: March 2010 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: April 8, 2011